US 12331056
SHP2 phosphatase inhibitors and methods of use thereof
granted A61PA61P35/00
Quick answer
US patent 12331056 (SHP2 phosphatase inhibitors and methods of use thereof) held by Relay Therapeutics, Inc. expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relay Therapeutics, Inc.
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P35/00